0NLY

VERBIO Vereinigte BioEnergie AG

Common Stock · EUR · XETRA

VBKT212

Price

€38.78

+0.36%

Cap

€2.39B

Earnings

30d Trend

+1.5%

0NLY
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityModerate

23% annualised over 90 days

BRAIN47 SIGNAL

0
ELITE
Risk Level25
Momentum62
Technical56
Fund Quality72
Cost Efficiency85

Raw weighted: 71×Macro 0.99 (1%)=70

RISK

25/100
90d Volatility
22.8%Moderate
ATR %
1.8%Normal
Max Drawdown (1Y)
-7.2%Resilient

MOMENTUM

62/100
6-1M Momentum
+8.9%Positive
1M Return
+7.4%Strong recent gains

TECHNICAL

56/100
RSI (14)
66.0Neutral
MACD
+0.22Bullish momentum
Bollinger Band
94%Near upper band
Trend Quality (KER)
0.336Mixed

FUND QUALITY

72/100
Replication
PhysicalHolds actual assets
Holdings
585 positionsHighly diversified
Domicile
USADomestic
Yield
1.05% (Distributing)Moderate

COST EFFICIENCY

85/100
Expense Ratio
0.07%Ultra-low cost
Fund Size (AUM)
$44.9BLarge fund

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months59
3-12 months66
1-5+ years78

Long-term compounder — quality business with growth runway

BRAIN47'S ASSESSMENT

I rate VERBIO Vereinigte BioEnergie AG at 70/100 — a ELITE reading on the Brain47 Signal. The strongest factor is cost efficiency at 85/100. I classify this as a growth position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

+7.4%

3 MONTHS

12 MONTHS

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder — quality business with growth runway. Cost Efficiency (85) and low-risk profile are the primary strengths. Historical volatility is normal at 23%. I classify this as a growth position — positive trend direction combined with solid fundamentals points to capital appreciation.

growthScore: 70/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.